Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Daphne S. Bakker; Julia Drylewicz; Stefan Nierkens; Edward F. Knol; Barbara Giovannone; Eveline M. Delemarre; Jorien van der Schaft; Deepak M.W. Balak; Marjolein S. de Bruin-Weller; Judith L. Thijs

doi:10.1111/cea.13495

Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

Daphne S. Bakker, Julia Drylewicz, Stefan Nierkens, Edward F. Knol, Barbara Giovannone, Eveline M. Delemarre, Jorien van der Schaft, Deepak M.W. Balak, Marjolein S. de Bruin-Weller, Judith L. Thijs

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	1641-1644
Number of pages	4
Journal	Clinical and Experimental Allergy
Volume	49
Issue number	12
DOIs	https://doi.org/10.1111/cea.13495
Publication status	Published - 1 Dec 2019
Externally published	Yes

Access to Document

10.1111/cea.13495

Cite this

@article{b744a24001dc4e9a816ce4a1b746241f,

title = "Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment",

author = "Bakker, {Daphne S.} and Julia Drylewicz and Stefan Nierkens and Knol, {Edward F.} and Barbara Giovannone and Delemarre, {Eveline M.} and {van der Schaft}, Jorien and Balak, {Deepak M.W.} and {de Bruin-Weller}, {Marjolein S.} and Thijs, {Judith L.}",

note = "Funding Information: MS de Bruin-Weller: consultant for Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; an advisory board member for AbbVie, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; and principal investigator for AbbVie, Regeneron Pharmaceuticals, Inc, Roche, Sanofi Genzyme. The other authors have no conflicts of interest to declare.",

year = "2019",

month = dec,

day = "1",

doi = "10.1111/cea.13495",

language = "English",

volume = "49",

pages = "1641--1644",

journal = "Clinical and Experimental Allergy",

issn = "0954-7894",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "12",

}

TY - JOUR

T1 - Early identification of atopic dermatitis patients in need of systemic immunosuppressive treatment

AU - Bakker, Daphne S.

AU - Drylewicz, Julia

AU - Nierkens, Stefan

AU - Knol, Edward F.

AU - Giovannone, Barbara

AU - Delemarre, Eveline M.

AU - van der Schaft, Jorien

AU - Balak, Deepak M.W.

AU - de Bruin-Weller, Marjolein S.

AU - Thijs, Judith L.

N1 - Funding Information: MS de Bruin-Weller: consultant for Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; an advisory board member for AbbVie, Regeneron Pharmaceuticals, Inc, Sanofi Genzyme; and principal investigator for AbbVie, Regeneron Pharmaceuticals, Inc, Roche, Sanofi Genzyme. The other authors have no conflicts of interest to declare.

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85073994978&partnerID=8YFLogxK

U2 - 10.1111/cea.13495

DO - 10.1111/cea.13495

M3 - Letter

C2 - 31520450

AN - SCOPUS:85073994978

SN - 0954-7894

VL - 49

SP - 1641

EP - 1644

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

IS - 12

ER -